Activation of AMPK by these EGCG analogs resulted in the inhibition of cell proliferation, up-regulation of the cyclin-dependent kinase inhibitor p21, downregulation of the mTOR pathway, and suppression of stem cell population in human breast cancer cells. This evidence concerns the gene MTOR and breast carcinoma.